4-Ethyl-2-methylthiazole-5-carboxylic acid, 95.0%, 1g

Bis [3-(triethoxysilyl )propyl ] tetrasulphide, 90%+, 500g

(4-(((Benzyloxy)carbonyl)(ethyl)amino)phenyl)boronic acid, 95.0%, 5g

5-Ethynyl-dU-CEP, ≥90%, 1 g, emballage plastique.

Ethyl trimethylsilyldifluoroacetate, 95.0%, 25g

Cefpodoxime, 98%, 5mg

Fmoc-D-Thr(tBu)-OH, 97%, 25g

2,4-DIMETHYLBENZO[H]QUINOLIN-10-OL, 95.0%, 250mg

2-amino-4-(4-fluorophenyl)-5-methylthiophene-3-carbonitrile, 95.0%, 1g

1-Propyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

4-Nitrocumene>98.0%(GC)25g

5-Bromo-1-ethylpyridin-2(1H)-one, 95.0%, 5g

5-Amino-1,3-dimethyl-6-(3-propoxyphenoxy)-1H-benzo[d]imidazol-2(3H)-one, 97%, 1g